Skip to content

Intravenous Fluids After Laparoscopic Cholecystectomy

Intravenous Fluids After Laparoscopic Cholecystectomy: Necessary or Dispensable. A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03142464
Enrollment
100
Registered
2017-05-05
Start date
2015-07-01
Completion date
2016-07-30
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Electrolyte Disorders, Hunger, Postoperative Nausea, Postoperative Vomiting, Renal Function Abnormal, Thirst

Keywords

saline solution, laparoscopy, cholecystectomy, outcomes

Brief summary

Perioperative intravenous fluid (IV) administration has been the standard procedure since 1832 and, is a widely used practice sometimes under inadequate criteria. The present work aims at verifying the clinical need that justifies the common IV fluid prescription on the postoperative (PO) period in patients undergoing videolaparoscopic cholecystectomy (CVL) elective.

Detailed description

Patients undergoing elective laparoscopy cholecystectomies were randomized to either routine practice fluid prescription (control group) or no IV fluids in the postoperative period. Thirst, hunger, presence of nausea and vomiting, renal function and personal satisfaction were assessed. Body composition was evaluated by bioimpedance

Interventions

OTHERSuspension of the IV fluids

No IV fluids prescription, IV catheter filled with saline solution

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Controls - convention postoperative IV fluids; intervention arm - no IV fluids postoperative

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Elective laparoscopy cholescitectomy; no intraoperative complication -

Exclusion criteria

Co-existing severe renal failure, cardiac failure or pulmonary disease \-

Design outcomes

Primary

MeasureTime frameDescription
Renal function24 hoursSerum creatinine

Secondary

MeasureTime frameDescription
Presence of thirst24 hoursVisual analog scale
Presence of nausea24 hoursVisual analog scale
Total intravenous prescribed fluids per body weight24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026